In the last few decades, extensive research has been conducted by scientists and investigators to improve the quality of life and overall health in diabetics. One of the leading causes of morbidity and mortality in the United States and across the world, Diabetes has affected millions, and the disease’s prevalence is persistently rising. In an effort to further advance treatment options for the disease, Texas Children’s Hospital has extended its research contributions in unveiling hidden mysteries of Type 1 Diabetes by adding renowned immunologists and researchers Dr. Maria Bettini and her husband Dr. Matt Bettini to their research team of Texas Children’s Hospital.
“Team Bettini’s” research focus is to study the immunological mechanisms that are responsible for the destruction of pancreatic cells in the setting of Type 1 Diabetes. Before joining the research program at Texas Children’s Hospital and accepting the position of assistant professor in the Baylor College of Medicine’s department of Pediatric Diabetes and Endocrinology, the two researchers were working at The Robert and Janice McNair Foundation.
The two scholars received their training under leading immunologist and researcher, Dr. Dario Vignali at St. Jude’s Hospital. Matt Bettini’s primary area of interest is the class of immune cells that elicit a strong autoimmune response; whereas the focus of Maria Bettini’s research is to identify cells that execute the immune-mediated destruction.
Read more diabetes related news here:
[feed url=”http://bionews-tx.com/news/news-category/diabetes/feed” number=”5″ ]
Professor of Pediatrics in the department of Pathology and Immunology at Baylor College of Medicine and Chief of Immunology, Allergy and Rheumatology at Texas Children’s Hospital, Dr. Jordan Orange, commented on the addition of Bettinis to the immunological research team of Texas Children’s Hospital in these words:
“Matt and Maria Bettini are rising stars in the study of the immunology of diabetes. Their impact on the field has already been profound and we are delighted that they will unfold the next stage of their careers at Texas Children’s Hospital. We are excited for the undeniable synergies in working with the Bettinis to accelerate our research of immune-mediated disease.”
Dr. Matthew Bettini Earned his doctorate in Molecular pathogenesis and Immunology at Emory University in Atlanta, GA, and has been awarded the renowned Hartwell Fellowship Award. He is is regarding as an up and coming academic and research leader in his field and is also the author of several research-related publications in scientific and medical journals.
After earning her doctorate in immunology and molecular pathogenesis from Emory University, Maria Bettini pursued her postdoctoral fellowship at St. Jude Children’s Research Hospital. She is a recipient of several awards and honors during her doctoral and post-doctoral fellowship, which also includes research grants for her immune cell research. Maria has also authored several research publications for renowned medical journals like The Journal of Immunology, Immunity and Diabetes.
Chief of Pediatric Diabetes and Endocrinology at Baylor College of Medicine and Chief of service at Texas Children’s Diabetes and Endocrinology Center, Dr. Jake Kushner commented on the wife-husband team in these words:
“Matt and Maria are two of the smartest, nicest and most dedicated young scientists I’ve ever met. They have a sincere joy for discovery, as well as a collaborative spirit. Their presence will invigorate the type 1 diabetes research community here at Texas Children’s and we’re all looking forward to working with them.”
The pediatric department of Diabetes & Endocrinology at The Texas Children’s Hospital has emerged as a leader in the past few decades by devising therapeutic and non-traditional treatment strategies for pediatric-aged children to manage endocrine abnormalities. With collaboration and contribution from the world’s leading scientists, the research team of Texas Children’s Hospital is striving to improve the health standards of pediatric-aged children and adults.